Cutaneous T-Cell Lymphomas (CTCL) (Management and Treatment in Geriatric Patients)

Stoll JR, Willner J, Oh Y, Pulitzer M, Moskowitz A, Horwitz S, et al. Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sezary syndrome. Part I: Clinical and histologic features and diagnosis. J Am Acad Dermatol. 2021;85(5):1073-90.

Kempf W, Mitteldorf C, Cerroni L, Willemze R, Berti E, Guenova E, et al. Classifications of cutaneous lymphomas and lymphoproliferative disorders: An update from the EORTC cutaneous lymphoma histopathology group. J Eur Acad Dermatol Venereol. 2024;38(8):1491-503.

Korgavkar K, Xiong M, Weinstock M. Changing incidence trends of cutaneous T-cell lymphoma. JAMA Dermatol. 2013;149(11):1295-9.

Cai ZR, Chen ML, Weinstock MA, Kim YH, Novoa RA, Linos E. Incidence Trends of Primary Cutaneous T-Cell Lymphoma in the US From 2000 to 2018: A SEER Population Data Analysis. JAMA Oncol. 2022;8(11):1690-2.

Criscione VD, Weinstock MA. Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002. Arch Dermatol. 2007;143(7):854-9.

Bagherani N, Smoller BR. An overview of cutaneous T cell lymphomas. F1000Res. 2016;5.

Sidiropoulos KG, Martinez-Escala ME, Yelamos O, Guitart J, Sidiropoulos M. Primary cutaneous T-cell lymphomas: a review. J Clin Pathol. 2015;68(12):1003-10.

Lebowitz E, Geller S, Flores E, Pulitzer M, Horwitz S, Moskowitz A, et al. Survival, disease progression and prognostic factors in elderly patients with mycosis fungoides and Sezary syndrome: a retrospective analysis of 174 patients. J Eur Acad Dermatol Venereol. 2019;33(1):108-14.

Hristov AC, Tejasvi T, R AW. Cutaneous T-cell lymphomas: 2021 update on diagnosis, risk-stratification, and management. Am J Hematol. 2021;96(10):1313-28.

Tarabadkar ES, Shinohara MM. Skin Directed Therapy in Cutaneous T-Cell Lymphoma. Front Oncol. 2019;9:260.

Trautinger F, Eder J, Assaf C, Bagot M, Cozzio A, Dummer R, et al. European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sezary syndrome - Update 2017. Eur J Cancer. 2017;77:57-74.

Denis D, Beneton N, Laribi K, Maillard H. Management of mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL): focus on chlormethine gel. Cancer Manag Res. 2019;11:2241-51.

MacArthur KM, Jariwala N, Kim EJ, Rook AH. Topical Carmustine as Monotherapy or as Multimodality Therapy for Folliculotropic Mycosis Fungoides. Acta Derm Venereol. 2017;97(3):373-4.

Sivanand A, Surmanowicz P, Alhusayen R, Hull P, Litvinov IV, Zhou Y, et al. Immunotherapy for Cutaneous T-Cell Lymphoma: Current Landscape and Future Developments. J Cutan Med Surg. 2019;23(5):537-44.

Olsen EA, Hodak E, Anderson T, Carter JB, Henderson M, Cooper K, et al. Guidelines for phototherapy of mycosis fungoides and Sezary syndrome: A consensus statement of the United States Cutaneous Lymphoma Consortium. J Am Acad Dermatol. 2016;74(1):27-58.

Marka A, Carter JB. Phototherapy for Cutaneous T-Cell Lymphoma. Dermatol Clin. 2020;38(1):127-35.

Caccavale S, Tancredi V, Vitiello P, Sica A, Ronchi A, Franco R, et al. Photodynamic Therapy as an Effective Treatment for Cutaneous Lymphomas. Pharmaceutics. 2022;15(1).

Liu WT, Wang HT, Yeh YH, Wong TW. An Update on Recent Advances of Photodynamic Therapy for Primary Cutaneous Lymphomas. Pharmaceutics. 2023;15(5).

Vitiello P, Sagnelli C, Ronchi A, Franco R, Caccavale S, Mottola M, et al. Multidisciplinary Approach to the Diagnosis and Therapy of Mycosis Fungoides. Healthcare (Basel). 2023;11(4).

Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome): part II. Prognosis, management, and future directions. J Am Acad Dermatol. 2014;70(2):223 e1-17; quiz 40-2.

Van-de-Velde V, Zhou Y. Existing and Emerging Therapies for Cutaneous T-Cell Lymphoma. J Cutan Med Surg. 2019;23(3):319-27.

Zic JA. The treatment of cutaneous T-cell lymphoma with photopheresis. Dermatol Ther. 2003;16(4):337-46.

Oh Y, Stoll JR, Moskowitz A, Pulitzer M, Horwitz S, Myskowski P, et al. Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sezary syndrome. Part II: Prognosis and management. J Am Acad Dermatol. 2021;85(5):1093-106.

Salant JA, Khan N, Nelson JE, Norton-Westbrook M, Desai AV. Top Ten Tips Palliative Care Clinicians Should Know About Caring for Patients with Cutaneous T Cell Lymphoma. J Palliat Med. 2022;25(6):958-63.